Common Stock, Shares Authorized of TuHURA Biosciences, Inc./NV from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
TuHURA Biosciences, Inc./NV quarterly Common Stock, Shares Authorized in shares history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • TuHURA Biosciences, Inc./NV Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 200,000,000, a 167% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

TuHURA Biosciences, Inc./NV Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 200,000,000 +125,000,000 +167% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 200,000,000 +125,000,000 +167% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 75,000,000 0 0% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 75,000,000 0 0% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 75,000,000 0 0% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 75,000,000 0 0% 30 Jun 2024 10-Q 14 Nov 2024 2025 Q1
Q1 2024 75,000,000 +69,500,000 +1264% 31 Mar 2024 10-Q 14 May 2024 2024 Q3
Q4 2023 75,000,000 +69,500,000 +1264% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 75,000,000 -200,000,000 -73% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q1
Q2 2023 75,000,000 +69,500,000 +1264% 30 Jun 2023 10-K 07 Oct 2024 2024 FY
Q1 2023 5,500,000 -169,500,000 -97% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 5,500,000 -169,500,000 -97% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q2
Q3 2022 275,000,000 +100,000,000 +57% 30 Sep 2022 10-Q 09 Nov 2022 2023 Q1
Q2 2022 5,500,000 -169,500,000 -97% 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q1 2022 175,000,000 +80,000,000 +84% 31 Mar 2022 10-Q 13 May 2022 2022 Q3
Q4 2021 175,000,000 +80,000,000 +84% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q2
Q3 2021 175,000,000 +80,000,000 +84% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q1
Q2 2021 175,000,000 +80,000,000 +84% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 95,000,000 0 0% 31 Mar 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 95,000,000 0 0% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q2
Q3 2020 95,000,000 0 0% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 95,000,000 0 0% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 95,000,000 +88,000,000 +1257% 31 Mar 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 95,000,000 +25,000,000 +36% 31 Dec 2019 10-Q 13 Feb 2020 2020 Q2
Q3 2019 95,000,000 +25,000,000 +36% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q1
Q2 2019 95,000,000 +88,000,000 +1257% 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q1 2019 7,000,000 -43,000,000 -86% 31 Mar 2019 10-Q 14 May 2019 2019 Q3
Q4 2018 70,000,000 +20,000,000 +40% 31 Dec 2018 10-Q 11 Feb 2019 2019 Q2
Q3 2018 70,000,000 +20,000,000 +40% 30 Sep 2018 10-Q 13 Nov 2018 2019 Q1
Q2 2018 7,000,000 +2,000,000 +40% 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q1 2018 50,000,000 0 0% 31 Mar 2018 10-Q 15 May 2018 2018 Q3
Q4 2017 50,000,000 0 0% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q2
Q3 2017 50,000,000 0 0% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 5,000,000 -45,000,000 -90% 30 Jun 2017 8-K 03 Jun 2019
Q1 2017 50,000,000 -150,000,000 -75% 31 Mar 2017 10-Q 12 May 2017 2017 Q3
Q4 2016 50,000,000 -150,000,000 -75% 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 50,000,000 -150,000,000 -75% 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q2 2016 50,000,000 0 0% 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q1 2016 200,000,000 0 0% 31 Mar 2016 10-Q 12 May 2016 2016 Q3
Q4 2015 200,000,000 0 0% 31 Dec 2015 10-Q 12 Feb 2016 2016 Q2
Q3 2015 200,000,000 0 0% 30 Sep 2015 10-Q 16 Nov 2015 2016 Q1
Q2 2015 50,000,000 -150,000,000 -75% 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q1 2015 200,000,000 0 0% 31 Mar 2015 10-Q 15 May 2015 2015 Q3
Q4 2014 200,000,000 0 0% 31 Dec 2014 10-Q 12 Feb 2015 2015 Q2
Q3 2014 200,000,000 0 0% 30 Sep 2014 10-Q 07 Nov 2014 2015 Q1
Q2 2014 200,000,000 0 0% 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q1 2014 200,000,000 0 0% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 200,000,000 0 0% 31 Dec 2013 10-K 28 Aug 2014 2014 FY
Q3 2013 200,000,000 +125,000,000 +167% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 200,000,000 0 0% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 200,000,000 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 200,000,000 31 Dec 2012 10-K 28 Aug 2014 2014 FY
Q3 2012 75,000,000 30 Sep 2012 10-Q/A 20 Dec 2012 2013 Q1
Q2 2012 200,000,000 +125,000,000 +167% 30 Jun 2012 10-Q 18 Jan 2013 2013 Q2
Q2 2011 75,000,000 30 Jun 2011 10-K/A 20 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.